An extended-established drug with a various medical historical past is drawing new consideration for its potential position in treating an ultra-rare and life-threatening genetic dysfunction. Early findings counsel {that a} medication first developed a long time in the past might tackle an sudden new position in treating Bachmann-Bupp syndrome (BABS), a devastating and ultra-rare situation with no established remedy. […]
Source link
An extended-term research suggests {that a} particular blood biomarker might reveal the earliest organic shifts linked to Alzheimer’s illness, even earlier than standard mind imaging detects them. Credit...
Read more










